International Society For Pharmaceutical Engineering Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 118,215 | 134,132 | −15,917 | 4.9 | — |
| 2012 | 128,283 | 94,196 | 34,087 | 11.3 | — |
| 2013 | 226,919 | 250,280 | −23,361 | 3.1 | 0% |
| 2014 | 68,530 | 61,609 | 6,921 | 14.0 | — |
| 2015 | 94,930 | 87,604 | 7,326 | 10.9 | — |
| 2016 | 73,066 | 59,266 | 13,800 | 18.8 | — |
| 2017 | 69,544 | 59,084 | 10,460 | 21.0 | — |
| 2018 | 65,440 | 59,359 | 6,081 | 22.2 | — |
| 2019 | 66,299 | 67,153 | −854 | 19.4 | — |
| 2020 | 10,978 | 17,869 | −6,891 | 68.4 | — |
| 2021 | 45,217 | 36,921 | 8,296 | 35.8 | — |
| 2022 | 48,850 | 54,610 | −5,760 | 22.9 | — |
| 2023 | 75,897 | 79,577 | −3,680 | 15.2 | — |
In its most recent public year (2023), this organization spent $3,680 more than it brought in. Its reserves stood at about 15.2 months of spending, up from 4.9 in 2011.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works